Did we overcome rheumatic heart disease or is it still a public disease burden?
Rheumatic heart disease (RHD), affecting approximately 32 million people all over the world is one of the major causes of cardiovascular morbidity and mortality especially in developing countries. In this ongoing pilot study, we aim to investigate the prevalence of both definitive and borderline RHD...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Turaz Bilim
2018-03-01
|
| Series: | Medicine Science |
| Subjects: | |
| Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=281563 |
| _version_ | 1797329265864212480 |
|---|---|
| author | Erkan Yildirim Baris Bugan |
| author_facet | Erkan Yildirim Baris Bugan |
| author_sort | Erkan Yildirim |
| collection | DOAJ |
| description | Rheumatic heart disease (RHD), affecting approximately 32 million people all over the world is one of the major causes of cardiovascular morbidity and mortality especially in developing countries. In this ongoing pilot study, we aim to investigate the prevalence of both definitive and borderline RHD in Turkey as a developing country.
A total of 386 healthy young individuals (45 female, 341 males) who applied to our Cardiology Clinic for being military personnel coming from different regions of Turkey in the year 2015, were recruited for our study. 2012 World Heart Federation (WHF) criteria for echocardiographic assessment and diagnosis of RHD were used. Study population was classified into one of the three groups as normal, borderline RHD and definitive RHD. The three groups were similar in terms of baseline characteristics and laboratory findings. Definitive and borderline RHD were found in 11 (2,9%) and 29 (7,5%) individuals, respectively. Abnormal thickening of the anterior mitral valve leaflet (AMVL) was found statistically significant between the normal and the RHD groups (3.1±0.6 vs 4.2±0.9, p [Med-Science 2018; 7(1.000): 186-190] |
| first_indexed | 2024-03-08T07:02:17Z |
| format | Article |
| id | doaj.art-f369e9d1ede4432d8347530c7331d08f |
| institution | Directory Open Access Journal |
| issn | 2147-0634 |
| language | English |
| last_indexed | 2024-03-08T07:02:17Z |
| publishDate | 2018-03-01 |
| publisher | Society of Turaz Bilim |
| record_format | Article |
| series | Medicine Science |
| spelling | doaj.art-f369e9d1ede4432d8347530c7331d08f2024-02-03T05:37:10ZengSociety of Turaz BilimMedicine Science2147-06342018-03-017118619010.5455/medscience.2017.06.8683281563Did we overcome rheumatic heart disease or is it still a public disease burden?Erkan Yildirim0Baris BuganGulhane Training and Research Hospital, Department of Cardiology, Ankara, Turkey Dr. Suat Gunsel University of Kyrenia Hospital, Department of Cardiology, Krenia, Mersin, TurkeyRheumatic heart disease (RHD), affecting approximately 32 million people all over the world is one of the major causes of cardiovascular morbidity and mortality especially in developing countries. In this ongoing pilot study, we aim to investigate the prevalence of both definitive and borderline RHD in Turkey as a developing country. A total of 386 healthy young individuals (45 female, 341 males) who applied to our Cardiology Clinic for being military personnel coming from different regions of Turkey in the year 2015, were recruited for our study. 2012 World Heart Federation (WHF) criteria for echocardiographic assessment and diagnosis of RHD were used. Study population was classified into one of the three groups as normal, borderline RHD and definitive RHD. The three groups were similar in terms of baseline characteristics and laboratory findings. Definitive and borderline RHD were found in 11 (2,9%) and 29 (7,5%) individuals, respectively. Abnormal thickening of the anterior mitral valve leaflet (AMVL) was found statistically significant between the normal and the RHD groups (3.1±0.6 vs 4.2±0.9, p [Med-Science 2018; 7(1.000): 186-190]http://www.ejmanager.com/fulltextpdf.php?mno=281563Heart DiseaseAcute Rheumatic Feverand Public Disease Burden |
| spellingShingle | Erkan Yildirim Baris Bugan Did we overcome rheumatic heart disease or is it still a public disease burden? Medicine Science Heart Disease Acute Rheumatic Fever and Public Disease Burden |
| title | Did we overcome rheumatic heart disease or is it still a public disease burden? |
| title_full | Did we overcome rheumatic heart disease or is it still a public disease burden? |
| title_fullStr | Did we overcome rheumatic heart disease or is it still a public disease burden? |
| title_full_unstemmed | Did we overcome rheumatic heart disease or is it still a public disease burden? |
| title_short | Did we overcome rheumatic heart disease or is it still a public disease burden? |
| title_sort | did we overcome rheumatic heart disease or is it still a public disease burden |
| topic | Heart Disease Acute Rheumatic Fever and Public Disease Burden |
| url | http://www.ejmanager.com/fulltextpdf.php?mno=281563 |
| work_keys_str_mv | AT erkanyildirim didweovercomerheumaticheartdiseaseorisitstillapublicdiseaseburden AT barisbugan didweovercomerheumaticheartdiseaseorisitstillapublicdiseaseburden |